非酶性SETD1A活性通过环林K驱动乳腺癌细胞的增殖
Kanako Hayashi1,2, Takayuki Hoshii3, Meng Ning1
1Department of Molecular Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, 260-8670, Japan.
Breast cancer research : BCR
|August 12, 2025
概括
通过其与环林K的非酶功能,SETD1A促进乳腺癌细胞的复制.这个SETD1A-环林K轴为乳腺癌治疗提供了潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌是全球女性癌症死亡的主要原因.
- SETD1A是一种基因组甲基转移酶,与乳腺癌预后不佳有关.
- 在乳腺癌进展中SETD1A的确切作用需要进一步阐明.
研究的目的:
- 为了研究驱动乳腺癌中SETD1A依赖的分子机制.
- 了解SETD1A在乳腺癌细胞中的非酶功能.
主要方法:
- 使用TCGA和DepMap数据库识别高SETD1A乳腺癌细胞系.
- 在KPL-1细胞中SETD1A的CRISPR淘汰.
- RNA-seq,ChIP-seq,CRISPR-tiling选,以及救援实验. 这些实验包括:
主要成果:
- 在ER+/HER2乳腺癌中,SETD1A的表达很高,与较短的存活率相关.
- SETD1A对于细胞周期进展 (G1到S阶段) 独立于其催化域是必不可少的.
- 破坏SETD1A会影响DNA修复基因表达 (RPA3,PRIM1) 和转录延长.
- 非催化功能涉及循环K相关的FLOS域.
- 一种环林K降解剂CR8在ER+/HER2和三阴性乳腺癌 (TNBC) 细胞中模仿了SETD1A淘汰现象.
结论:
- SETD1A通过与环林K的非酶相互作用促进乳腺癌细胞的复制.
- SETD1A-cyclin K轴代表了包括TNBC在内的乳腺癌的有希望的治疗标.
更多相关视频
相关概念视频
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:39Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
01:23Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:38Mitogens and the Cell Cycle
6.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K